These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 8701417

  • 1. A prostacyclin-sparing effect of indobufen vs. aspirin.
    De Caterina R, Giannessi D, Bernini W, Lazzerini G, Lavezzari M, Stragliotto E, Biagi G, Coccheri S.
    Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
    [Abstract] [Full Text] [Related]

  • 2. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
    Greenberg HE, Gottesdiener K, Huntington M, Wong P, Larson P, Wildonger L, Gillen L, Dorval E, Waldman SA.
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
    [Abstract] [Full Text] [Related]

  • 3. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML, Tacconelli S, Sciulli MG, Grana M, Ricciotti E, Minuz P, Di Gregorio P, Merciaro G, Patrono C, Patrignani P.
    Circulation; 2004 Mar 30; 109(12):1468-71. PubMed ID: 15037526
    [Abstract] [Full Text] [Related]

  • 4. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
    Livio M, Benigni A, Zoja C, Begnis R, Morelli C, Rossini M, Garattini S, Remuzzi G.
    J Pharmacol Exp Ther; 1989 Jan 30; 248(1):334-41. PubMed ID: 2492341
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
    Sciulli MG, Renda G, Capone ML, Tacconelli S, Ricciotti E, Manarini S, Evangelista V, Rebuzzi A, Patrignani P.
    Clin Pharmacol Ther; 2006 Aug 30; 80(2):115-25. PubMed ID: 16890573
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.
    Circulation; 2007 Jun 26; 115(25):3156-64. PubMed ID: 17562955
    [Abstract] [Full Text] [Related]

  • 7. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb 26; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 8. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man.
    Bachi A, Brambilla R, Fanelli R, Bianchi R, Zuccato E, Chiabrando C.
    Br J Pharmacol; 1997 Aug 26; 121(8):1770-4. PubMed ID: 9283716
    [Abstract] [Full Text] [Related]

  • 9. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
    Frelinger AL, Furman MI, Linden MD, Li Y, Fox ML, Barnard MR, Michelson AD.
    Circulation; 2006 Jun 27; 113(25):2888-96. PubMed ID: 16785341
    [Abstract] [Full Text] [Related]

  • 10. Comparison of aspirin and indobufen in healthy volunteers.
    Lee JY, Sung KC, Choi HI.
    Platelets; 2016 Jun 27; 27(2):105-9. PubMed ID: 26083594
    [Abstract] [Full Text] [Related]

  • 11. The effect of two low doses of aspirin on whole blood thromboxane and prostacyclin generation in healthy subjects.
    Davì G, Custro N, Novo S, Mattina A, Strano A.
    Thromb Haemost; 1983 Oct 31; 50(3):669-70. PubMed ID: 6417815
    [Abstract] [Full Text] [Related]

  • 12. Human pharmacology of naproxen sodium.
    Capone ML, Tacconelli S, Sciulli MG, Anzellotti P, Di Francesco L, Merciaro G, Di Gregorio P, Patrignani P.
    J Pharmacol Exp Ther; 2007 Aug 31; 322(2):453-60. PubMed ID: 17473175
    [Abstract] [Full Text] [Related]

  • 13. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
    Hedegaard SS, Hvas AM, Grove EL, Refsgaard J, Rocca B, Daví G, Kristensen SD.
    Thromb Res; 2009 May 31; 124(1):96-100. PubMed ID: 19215971
    [Abstract] [Full Text] [Related]

  • 14. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
    Renda G, Tacconelli S, Capone ML, Sacchetta D, Santarelli F, Sciulli MG, Zimarino M, Grana M, D'Amelio E, Zurro M, Price TS, Patrono C, De Caterina R, Patrignani P.
    Clin Pharmacol Ther; 2006 Sep 31; 80(3):264-74. PubMed ID: 16952493
    [Abstract] [Full Text] [Related]

  • 15. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
    Zingarelli B, Southan GJ, Gilad E, O'Connor M, Salzman AL, Szabó C.
    Br J Pharmacol; 1997 Feb 31; 120(3):357-66. PubMed ID: 9031736
    [Abstract] [Full Text] [Related]

  • 16. Variable platelet response to aspirin in patients with ischemic stroke.
    Hohlfeld T, Weber AA, Junghans U, Schumacher M, Boucher M, Schrör K, Siebler M.
    Cerebrovasc Dis; 2007 Feb 31; 24(1):43-50. PubMed ID: 17519543
    [Abstract] [Full Text] [Related]

  • 17. The d-enantiomer form of indobufen totally accounts for the anti-cyclooxygenase and antiplatelet activity ex vivo and for the increase in bleeding time by indobufen in man.
    De Caterina R, Sicari R, Yan A, Bernini W, Giannessi D, Lazzerini G, Efthymiopoulos C, Strolin-Benedetti M.
    Thromb Haemost; 1992 Feb 03; 67(2):258-63. PubMed ID: 1621247
    [Abstract] [Full Text] [Related]

  • 18. Effect of picotamide on platelet aggregation and on thromboxane A2 production in vivo.
    Minuz P, Lechi C, Arosio E, Guzzo P, Zannoni M, Lauciello C, Lechi A.
    Thromb Haemost; 1991 Mar 04; 65(3):312-6. PubMed ID: 2048055
    [Abstract] [Full Text] [Related]

  • 19. Effects of very low dose and enteric-coated acetylsalicylic acid on prostacyclin and thromboxane formation and on bleeding time in healthy subjects.
    Bode-Böger SM, Böger RH, Schubert M, Frölich JC.
    Eur J Clin Pharmacol; 1998 Mar 04; 54(9-10):707-14. PubMed ID: 9923572
    [Abstract] [Full Text] [Related]

  • 20. Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin.
    Schiff M, Hochberg MC, Oldenhof J, Brune K.
    Curr Med Res Opin; 2009 Oct 04; 25(10):2471-7. PubMed ID: 19678751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.